Inhibrx

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Inhibrx and other ETFs, options, and stocks.

About INBX

Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. 

CEO
Mark P. Lappe
CEOMark P. Lappe
Employees
112
Employees112
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2010
Founded2010
Employees
112
Employees112

INBX Key Statistics

Market cap
1.16B
Market cap1.16B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
553.85K
Average volume553.85K
High today
$33.20
High today$33.20
Low today
$22.91
Low today$22.91
Open price
$29.00
Open price$29.00
Volume
7.51M
Volume7.51M
52 Week high
$47.90
52 Week high$47.90
52 Week low
$7.67
52 Week low$7.67

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

INBX Earnings

-$0.97
-$0.65
-$0.32
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, After Hours
ActualExpected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.